Publications by Medical Specialty - Genetics
These publications were authored or co-authored by Quest Diagnostics staff.
- Adult Medicine
- Clinical and Lab healthcare professionals
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Family medicine practitioners
- General Health and Wellness
- Geriatrics/Age Management
- Health Information Technology
- Infectious Disease
- Internal Medicine
- Nurse practitioners
- Pathology, Anatomic
- Pathology, Laboratory Medicine
- Physician assistants
- Prescription Drug Monitoring
- Primary Care
- Sports Medicine
- Toxicology/Pain Management
- Women's Health/OB/GYN
Authors: Meng H and Xu W
J Mol Genet Med. 2018 Oct 8;12(4)
An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease.
Authors: Kazi ZB, Desai AK, Troxler RB, Kronn D, Packman S, Sabbadini M, Rizzo WB, Scherer K, Abdul-Rahman O, Tanpaiboon P, Nampoothiri S, Gupta N, Feigenbaum A, Niyazov DM, Sherry L, Segel R, McVie-Wylie A, Sung C, Joseph AM, Richards S, Kishnani PS.
Genet Med. 2018 Sep 14. doi: 10.1038/s41436-018-0270-7. [Epub ahead of print]
A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer-Reply to letter to the editor by Petelin et al.
Authors: Li Y, Devlin JJ.
Value Health. 2018 Jul;21(7):893-894. Epub 2018 Apr 5.
Authors: Hoskovec JM, Bennett RL, Carey ME, DaVanzo JE, Dougherty M, Hahn SE, LeRoy BS, O'Neal S, Richardson JG, Wicklund CA.
J Genet Couns. 2018 Feb;27(1):16-20.
Authors: Chen N, Franklin CR, and Quan F
AMP CAP Today 2018 http://www.captodayonline.com/detection-rare-deletion-mutation-alpha-globin-gene-locus-establishes-diagnosis-hb-h-disease/ 2018;Feb. Accessed February 2018.
Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?
Authors: Majidi S, Fouts A, Pyle L, Chambers C, Armstrong T, Wang Z, Batish SD, Klingensmith G, Steck AK
Diabetes Technol Ther. 2018 Feb;20(2):106-112.
Disclaimer: One or more of the authors of this publication were employed at the time by Athena Diagnostics, a subsidiary of Quest Diagnostics.
Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability
Authors: Li Y, Anderson LA, Ginns EI, Devlin JJ
Mol Diagn Ther. 2018;22(1):129-138.
Authors: Hoskovec JM, Bennett RL, Carey ME, DaVanzo JE, Dougherty M, Hahn SE, LeRoy BS, O'Neal S, Richardson JG, Wicklund CA
J Genet Couns. 2017 Oct doi: 10.1007/s10897-017-0158-8. [Epub ahead of print]
Authors: Mentzel T, Kiss K
Virchows Arch. 2017 Oct 5. doi: 10.1007/s00428-017-2242-8. [Epub ahead of print]
Authors: Hemmat M, Rumple MJ, Mahon LW, Morrow M, Zach T, Anguiano A, Elnaggar MM, Wang BT, Boyar FZ
Mol Cytogenet 2017;10:33